Immupharma (IMM) Share Price

Health Care Sector


NOTE: This is based on 7 open tips for Immupharma (IMM)


Immupharma (IMM)
Latest Quote Price

2.10p

Immupharma (IMM)
Price Change (%)

0.72%


Latest Bid : 2.01p Latest Ask : 2.18p
High Today : 2.15p Low Today : 2.04p
This Years High : 2.61p This Years Low : 0.85p
Volume : 203,980 MKT Cap : £9.07M
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only


Immupharma (IMM) Overview

ImmuPharma PLC is a pharmaceutical development company focusing on developing novel medicines in specialist markets with serious unmet need. Lupuzor™ is the company's most advanced drug in development and is a treatment for lupus, a life threatening autoimmune disease and has now completed dosing Lupus patients in its Phase III pivotal trial. This is only part of our story as our scientists and researchers are developing drugs to make life changing difference to peoples lives worldwide.

Immupharma (IMM) Latest Tips

Type Tipster SectorScore Start date Performance
Buy Northland Capital Premium Only 2018-04-17 16:35:00 17/04/2018 -60.41%
Risky Buy Paul Summers Premium Only 2018-03-01 09:50:00 01/03/2018 -92.31%
Buy FinnCap Premium Only 2017-12-21 11:30:00 21/12/2017 -91.87%
Buy FinnCap Premium Only 2017-12-12 08:00:00 12/12/2017 -93.10%
Buy Harvey Jones Premium Only 2017-10-09 15:30:00 09/10/2017 -86.07%

You are missing Premium Content from this chart

Please Log In to a premium account or Sign Up today to view premium content.


Immupharma (IMM) Active Short Positions

Fund Manager Position Date
No active short positions

See more short positions...


Latest Bid : 2.01p Latest Ask : 2.18p
High Today : 2.15p Low Today : 2.04p
This Years High : 2.61p This Years Low : 0.85p
Volume : 203,980 MKT Cap : £9.07M

Immupharma Overview

ImmuPharma PLC is a pharmaceutical development company focusing on developing novel medicines in specialist markets with serious unmet need. Lupuzor™ is the company's most advanced drug in development and is a treatment for lupus, a life threatening autoimmune disease and has now completed dosing Lupus patients in its Phase III pivotal trial. This is only part of our story as our scientists and researchers are developing drugs to make life changing difference to peoples lives worldwide.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Latest Immupharma Tips

Type Tipster SectorScore Start date Performance
Buy Northland Capital Premium Only 2018-04-17 16:35:00 17/04/2018 -60.41%
Risky Buy Paul Summers Premium Only 2018-03-01 09:50:00 01/03/2018 -92.31%
Buy FinnCap Premium Only 2017-12-21 11:30:00 21/12/2017 -91.87%
Buy FinnCap Premium Only 2017-12-12 08:00:00 12/12/2017 -93.10%
Buy Harvey Jones Premium Only 2017-10-09 15:30:00 09/10/2017 -86.07%